Acquired 1,118 shares
of Common Stock, $0.01 par value
(Direct)
Date: 2026-05-08 |
Code: A
| equity_swap_involved: 0 | shares_owned_after: 2,321.00 | transaction_form_type: 4 | Footnotes: F1
Holds 0 shares
of Common Stock, $0.01 par value
(Direct)
Date: 2026-05-08 |
Code: H
| nature_of_ownership: By limited partnership | shares_owned_after: 3,000.00 | Footnotes: F2
Footnotes:
F1: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2: The securities are owned by a limited partnership that is jointly controlled by the reporting person and his spouse. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
🔍 FALK THOMAS J (Executive)
Company: AbbVie Inc. (ABBV)
Report Date: 2026-05-08
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,321.00 | transaction_form_type: 4 | Footnotes: F1
Date: 2026-05-08 | Code: H | nature_of_ownership: By limited partnership | shares_owned_after: 3,000.00 | Footnotes: F2
Footnotes: